Function of Appican and Sulfation Pattern in AD Brains
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000024
Summary
The amyloid precursor protein (APP) is produced in different forms (called isoforms), and one of these isoforms has been found by Dr. Shioi to be the core protein of a complex type of protein called a chondroitin sulfate proteoglycan (a protein that contains sulfur and sugar molecules). Dr. Shioi calls this APP-containing protein “appican.” Appican is found in brain tissue and is produced by a type of brain cell (called an astrocyte) in cell culture, but non-neuronal cell lines produce little or no appican. Recent evidence suggests that chondroitin sulfate proteoglycans are involved in neuronal growth and development. Dr. Shioi is examining the possible role of appican in normal brain function and whether this role is changed in Alzheimer’s disease (AD). The results of these experiments could identify a new role for the APP protein in AD.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University